Home/Filings/4/0001415889-25-007798
4//SEC Filing

Liawatidewi Yakob 4

Accession 0001415889-25-007798

CIK 0001297184other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:16 PM ET

Size

8.0 KB

Accession

0001415889-25-007798

Insider Transaction Report

Form 4
Period: 2025-03-10
Liawatidewi Yakob
DirectorEVP CORP ADMIN CENTER
Transactions
  • Award

    Common Stock

    2025-03-10+20,83793,671 total
  • Award

    Employee Stock Option (right to buy)

    2025-03-10+44,25344,253 total
    Exercise: $28.41Exp: 2035-03-10Common Stock (44,253 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    2,459
Footnotes (3)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 10, 2026.
  • [F2]The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
  • [F3]The shares subject to the option vest in four equal annual installments beginning on March 10, 2026.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001743927

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:16 PM ET
Size
8.0 KB